On September 24, 2013, FDA is conducting a public meeting on Patient-Focused Drug Development for narcolepsy. FDA is interested in obtaining patient input on the impact of narcolepsy on daily life and the available therapies for narcolepsy.
This website will be updated as
registration and additional meeting information become available.
| Date: |
September 24, 2013
|
| Time: |
1 p.m. to 5 p.m.
|
| Location: |
FDA White Oak
Campus
(Information
about arrival to FDA's White Oak campus)10903 New Hampshire Ave. Building 31, Room 1503A Silver Spring, MD 20993 |
| Registration: | To register for this
meeting, visit: http://patientfocusednarcolepsy.eventbrite.com
Registration will close on
September 13, 2013.
|
Submitting comments to the docket: In addition to providing input at the public meeting, patient stakeholders are invited to provide their perspectives on the discussion questions through the public docket. Visit the following website to provide electronic or written comments: http://www.regulations.gov/#!submitComment;D=FDA-2013-N-0815-0001
